Castle biosciences presents data reinforcing the clinical utility of its decisiondx® dermatologic portfolio

Friendswood, texas--(business wire)---- $cstl #cstl--castle announced oral presentations on its decisiondx® skin cancer tests at the american society for dermatologic surgery (asds) 2021 annual meeting.
CSTL Ratings Summary
CSTL Quant Ranking